Q3 2024 |
41 |
$123M |
+$31.1M |
-$45.5M |
-$14.4M |
PCVX, OCUL, TRML, INSM, ELVN
|
13F-HR |
11/14/2024, 07:06 AM |
Q2 2024 |
32 |
$119M |
+$19.1M |
-$39.6M |
-$20.5M |
OCUL, ELVN, PCVX, DYN, PRAX
|
13F-HR |
8/14/2024, 09:16 AM |
Q1 2024 |
33 |
$154M |
+$30.2M |
-$93.7M |
-$63.5M |
OCUL, PRAX, MRSN, TSHA, RCKT
|
13F-HR |
5/15/2024, 07:56 AM |
Q4 2023 |
38 |
$178M |
+$56.7M |
-$50.8M |
+$5.93M |
RYZB, CBAY, RCKT, KURA, EYPT
|
13F-HR |
2/14/2024, 10:29 AM |
Q3 2023 |
42 |
$138M |
+$42.1M |
-$27.9M |
+$14.2M |
TSHA, APLS, AADI, PRAX, RYZB
|
13F-HR |
11/14/2023, 09:16 AM |
Q2 2023 |
35 |
$148M |
+$39.3M |
-$33.7M |
+$5.66M |
APLS, AADI, TERN, KURA, SNDX
|
13F-HR |
8/14/2023, 07:49 AM |
Q1 2023 |
33 |
$128M |
+$12.4M |
-$34.6M |
-$22.3M |
APLS, AADI, TERN, CBAY, VTYX
|
13F-HR |
5/15/2023, 07:26 AM |
Q4 2022 |
34 |
$155M |
+$42.6M |
-$100M |
-$57.5M |
AADI, VRDN, APLS, TERN, UTHR
|
13F-HR |
2/14/2023, 04:08 PM |
Q3 2022 |
46 |
$225M |
+$48.2M |
-$35.6M |
+$12.5M |
APLS, AADI, BLU, RLMD, ISEE
|
13F-HR |
11/14/2022, 10:24 AM |
Q2 2022 |
41 |
$179M |
+$30.9M |
-$24.9M |
+$6.05M |
APLS, AADI, VTGN, KURA, BLSA
|
13F-HR |
8/15/2022, 06:10 PM |
Q1 2022 |
38 |
$210M |
+$34.9M |
-$30.1M |
+$4.88M |
APLS, AADI, VTGN, CLDX, RLMD
|
13F-HR |
5/16/2022, 08:37 AM |
Q4 2021 |
36 |
$238M |
+$64.2M |
-$87.7M |
-$23.5M |
AADI, APLS, VTGN, CLDX, GHRS
|
13F-HR |
2/14/2022, 08:12 AM |
Q3 2021 |
46 |
$281M |
+$100M |
-$79.4M |
+$20.8M |
AADI, VTGN, ISEE, CLDX, BLU
|
13F-HR |
11/15/2021, 02:24 PM |
Q2 2021 |
37 |
$234M |
+$29.7M |
-$85.6M |
-$55.9M |
VTGN, CLDX, APLS, ARWR, BLSA
|
13F-HR |
8/16/2021, 12:05 PM |
Q1 2021 |
46 |
$277M |
+$82.4M |
-$139M |
-$56.8M |
VTGN, CLDX, KURA, AVDL, ISEE
|
13F-HR |
5/17/2021, 11:27 AM |
Q4 2020 |
50 |
$363M |
+$93.3M |
-$126M |
-$33.2M |
CLDX, SAGE, KURA, LRMR, MRSN
|
13F-HR |
2/16/2021, 06:04 AM |
Q3 2020 |
42 |
$340M |
+$130M |
-$174M |
-$44M |
IMMU, KURA, CLDX, SAGE, CMPS
|
13F-HR |
11/16/2020, 12:17 PM |
Q2 2020 |
46 |
$346M |
+$151M |
-$75.6M |
+$75.1M |
ADVM, IMMU, BTAI, IOVA, MRSN
|
13F-HR |
8/14/2020, 04:22 PM |
Q1 2020 |
32 |
$206M |
+$61.8M |
-$139M |
-$76.7M |
AVDL, AXSM, ADVM, IOVA, ARVN
|
13F-HR |
5/15/2020, 04:11 PM |
Q4 2019 |
35 |
$352M |
+$152M |
-$42.5M |
+$109M |
AXSM, ARWR, KDMN, AUPH, ITCI
|
13F-HR |
2/14/2020, 10:50 AM |
Q3 2019 |
30 |
$127M |
+$24.9M |
-$121M |
-$96.3M |
KDMN, IOVA, ARVN, ARWR, AXSM
|
13F-HR |
11/13/2019, 09:15 PM |
Q2 2019 |
27 |
$259M |
+$82M |
-$73M |
+$8.96M |
IOVA, KDMN, ADVM, VCYT, ARWR
|
13F-HR |
8/14/2019, 03:36 PM |
Q1 2019 |
31 |
$208M |
+$75M |
-$11.4M |
+$63.5M |
IOVA, KDMN, ASMB, CASM, INSM
|
13F-HR |
5/13/2019, 09:46 PM |
Q4 2018 |
18 |
$116M |
+$16.9M |
-$91.3M |
-$74.4M |
IOVA, ASMB, KDMN, CASM, BHVN
|
13F-HR |
2/14/2019, 10:22 AM |
Q3 2018 |
23 |
$250M |
+$6.21M |
-$244M |
-$238M |
IMMU, ASMB, IOVA, KDMN, CEMI
|
13F-HR |
11/6/2018, 09:11 PM |
Q2 2018 |
37 |
$507M |
+$96.9M |
-$105M |
-$8.55M |
IMMU, IOVA, ASMB, ARGX, KDMN
|
13F-HR |
8/14/2018, 09:12 PM |
Q1 2018 |
30 |
$477M |
+$82.2M |
-$58.6M |
+$23.6M |
IMMU, IOVA, ASMB, ASND, ARGX
|
13F-HR |
5/15/2018, 06:13 AM |
Q4 2017 |
31 |
$403M |
+$52.9M |
-$38.1M |
+$14.8M |
IMMU, ASMB, IOVA, VCYT, ASND
|
13F-HR |
2/13/2018, 09:24 PM |
Q3 2017 |
35 |
$371M |
+$150M |
-$58M |
+$91.8M |
IMMU, ASMB, VCYT, IOVA, IRIX
|
13F-HR |
11/14/2017, 04:40 PM |
Q2 2017 |
35 |
$245M |
+$86.2M |
-$104M |
-$17.7M |
ASND, VCYT, IOVA, ASMB, IRIX
|
13F-HR |
8/11/2017, 06:07 PM |
Q1 2017 |
41 |
$277M |
+$73.9M |
-$95.9M |
-$22M |
VCYT, ASMB, LBIO, IRIX, ACAD
|
13F-HR |
5/15/2017, 06:20 AM |
Q4 2016 |
38 |
$251M |
+$71.4M |
-$64.1M |
+$7.24M |
VCYT, LBIO, IRIX, IMMU, EDGE
|
13F-HR |
2/13/2017, 04:26 PM |
Q3 2016 |
53 |
$243M |
+$66.3M |
-$55.5M |
+$10.9M |
LBIO, VCYT, IRIX, IMMU, EVDY
|
13F-HR |
11/15/2016, 06:04 AM |
Q2 2016 |
56 |
$199M |
+$69.5M |
-$45.6M |
+$23.9M |
LBIO, VCYT, IRIX, IMMU, RRM
|
13F-HR |
8/15/2016, 02:09 PM |
Q1 2016 |
36 |
$173M |
+$64.4M |
-$52M |
+$12.4M |
FOLD, VCYT, IMMU, LBIO, ASND
|
13F-HR |
5/13/2016, 05:05 PM |
Q4 2015 |
47 |
$188M |
+$85.3M |
-$53.2M |
+$32M |
OLED, LBIO, FOLD, VCYT, IMMU
|
13F-HR |
2/12/2016, 04:53 PM |
Q3 2015 |
52 |
$158M |
+$65.6M |
-$39.2M |
+$26.5M |
FOLD, EXEL, ASND, LBIO, BEAT
|
13F-HR |
11/16/2015, 04:43 PM |
Q2 2015 |
49 |
$153M |
+$75.1M |
-$37.1M |
+$38M |
FOLD, AGTC, VCYT, LBIO, ASND
|
13F-HR |
8/14/2015, 06:08 AM |
Q1 2015 |
46 |
$112M |
+$46.5M |
-$44.6M |
+$1.87M |
FOLD, LBIO, CEMP, ALIM, BEAT
|
13F-HR |
5/14/2015, 05:49 PM |
Q4 2014 |
54 |
$101M |
$0 |
$0 |
|
FOLD, ALIM, PTX, BEAT, LMAT
|
13F-HR |
2/12/2015, 05:54 PM |